Edoxaban in acute PE and DVT: Focus on the Hokusai-VTE Study

Dr Samuel Goldhaber

Disclosures

September 02, 2013

This feature requires the newest version of Flash. You can download it here.


ESC Congress 2013 was buzzing with the results of the Hokusai-VTE Study. From the convention floor, Dr Samuel Goldhaber shares his excitement for the new NOA kid on the block.

See:

Hokusai-VTE Study: Once-daily edoxaban matches warfarin for averting recurrent DVT, PE

The Hokusai-VTE investigators. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. New Engl J Med 2013; DOI:10.1056/NEJMoa1306638. Available at: http://www.nejm.org.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....